Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 18Gastrointestinal 12Genitourinary 6Tumor-Agnostic 4Head & Neck 3Gynecologic 3Thoracic 1Lymphoid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Ovarian Neoplasms 2Uterine Cervical Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Decision Support Techniques × Gynecologic × Clear all
NCT05512260 2026-02-11

BESTa

Karolinska Institutet

Phase NA Withdrawn
BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT02259699 2019-06-10

PCOA

University of California, Irvine

Phase NA Completed
124 enrolled 11 charts
Gynecologic

Ovarian Neoplasms

NCT00119509 2007-04-25

The IMAP Study Improving Management of Mildly Abnormal Pap Smears

University of Sydney

Phase 3 Unknown
300 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡